Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.990
-0.010 (-1.00%)
At close: Nov 7, 2024, 4:00 PM
1.030
+0.040 (4.04%)
After-hours: Nov 7, 2024, 5:45 PM EST
Rallybio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 41 | 90 | 249 | 307 | - | - |
| Market Cap Growth | -74.00% | -63.67% | -18.90% | - | - | - |
| Enterprise Value | -47 | -31 | 117 | 120 | - | - |
| Last Close Price | 0.99 | 2.39 | 6.57 | 9.54 | - | - |
| PE Ratio | - | -1.30 | -3.14 | -5.18 | - | - |
| PB Ratio | 0.51 | 0.85 | 1.47 | 1.75 | - | - |
| P/FCF Ratio | -1.03 | -1.50 | -4.34 | -6.68 | - | - |
| P/OCF Ratio | -1.03 | -1.50 | -4.34 | -6.73 | - | - |
| EV/EBITDA Ratio | 0.52 | 0.39 | -1.72 | -2.63 | - | - |
| EV/EBIT Ratio | 0.52 | 0.39 | -1.72 | -2.62 | - | - |
| EV/FCF Ratio | 0.71 | 0.51 | -2.04 | -2.61 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | - | - |
| Debt / FCF Ratio | -0.01 | -0.01 | -0.01 | - | - | - |
| Quick Ratio | 7.29 | 11.87 | 15.73 | 26.76 | 24.00 | 5.11 |
| Current Ratio | 7.52 | 12.39 | 16.71 | 27.61 | 24.18 | 5.50 |
| Return on Equity (ROE) | -67.39% | -54.13% | -38.65% | -30.17% | -34.60% | - |
| Return on Assets (ROA) | -38.54% | -33.33% | -23.40% | -17.61% | -19.35% | - |
| Return on Capital (ROIC) | -42.04% | -35.69% | -24.56% | -18.31% | -20.69% | - |
| Earnings Yield | -179.88% | -82.55% | -26.81% | -15.34% | - | - |
| FCF Yield | -131.48% | -66.73% | -23.06% | -14.96% | - | - |
| Buyback Yield / Dilution | -12.99% | -27.11% | -24.70% | -46.76% | -913.79% | - |
| Total Shareholder Return | -12.99% | -27.11% | -24.70% | -46.76% | -913.79% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.